Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Validus Pharmaceuticals Inc.

www.validuspharma.com

Latest From University of Wisconsin

Deals Shaping the Medical Industry, April 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.

BioPharmaceutical Medical Device

FDA Gastroenterology, Radiology Advisors Finally Agree: CT Colonography Benefits Outweigh Risks

New research findings presented at a joint meeting of FDA’s gastroenterology and radiological devices panels persuaded experts that CT colonography is safe and works well for screening adults over 50 for colorectal cancer.

Medical Device

No Advantage For Medtronic’s InFuse Versus Bone Graft In Spine Fusion

The long-awaited independent analysis of clinical data on Medtronic’s InFuse recombinant human bone morphogenetic protein-2 (rhBMP-2) found no advantages to using it as a substitute for traditional bone grafts in spinal fusion surgery, while also revealing that the risks of rhBMP-2 may be greater than has been previously reported.

Medical Device

Recent Financings Of Private Companies, April 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Validus Pharmaceuticals Inc.
  • Senior Management
  • James Hunter, Pres. & CEO
    Richard Post, VP, Sales & Mktg.
  • Contact Info
  • Validus Pharmaceuticals Inc.
    Phone: (973) 265-2777
    119 Cherry Hill Rd.
    Ste. 310
    Parsippany, NJ 07054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register